Natco Pharma Limited Imatinib Export Data — India (DGFT 2022–2026)

Name: Natco Pharma Limited Imatinib Export Records India — #5 Exporter, 33 Shipments, $1.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Imatinib

India Pharmaceutical Trade Intelligence

$29.3M224 Suppliers119 CountriesHS 30049049

ExportsIndia → UNITED STATES24.3%India → BELGIUM12.4%

ImportsGERMANY → India$331.7M UNITED STATES → India$584.7K

#1 Supplier: CIPLA LIMITED #1 Buyer: H.ESSERS &

Natco Pharma Limited — Imatinib Exporter #5 | $1.3M Trade Value | TransData Nexus | TransData Nexus

Natco Pharma Limited — Imatinib Exporter Profile

Indian Pharmaceutical Exporter · #5 for Imatinib · $1.3M export value · DGFT Verified

Natco Pharma Limited is the #5 Indian exporter of Imatinib with $1.3M in export value and 33 verified shipments. Natco Pharma Limited holds a 4.5% market share in Imatinib exports across 9 countries. The company exports 17 pharmaceutical products worth $36.0M across 6 therapeutic categories.

Natco Pharma Limited — Imatinib Export Profile: Buyers & Destinations

Natco Pharma Limited Imatinib export treemap — buyers and destination countries | TransData Nexus

Where Does Natco Pharma Limited Export Imatinib?

Country	Value	Shipments	Share
THAILAND	$305.3K	7	28.2%
GERMANY	$240.8K	8	22.2%
CANADA	$234.1K	6	21.6%
CZECH REPUBLIC	$136.8K	5	12.6%
BANGLADESH	$74.8K	2	6.9%

Who Are the Top Buyers of Imatinib from Natco Pharma Limited?

Buyer	Country	Value	Orders
ATLANTA MEDICARE CO. LTD	THAILAND	$205.3K	5
NATCO PHARMA (CANADA) INC	CANADA	$184.5K	5
STADA ARZNEIMITTEL AG,	GERMANY	$138.5K	5
TO THE CONSIGNEE OF	BANGLADESH	$74.8K	2
MEDIS INTERNATIONAL A.S,	CZECH REPUBLIC	$67.1K	2
MEDIS INTERNATIONAL ASPRODUCTION PLANT BOLATICE PRUMYSLOVA	CZECH REPUBLIC	$53.9K	2
STADA ARZNEIMITTEL AG D	GERMANY	$52.3K	2
NATCO PHARMA ASIA PTE LTD,	SINGAPORE	$50.0K	1
STADAPHARM GMBH	GERMANY	$50.0K	1
ATLANTA MEDICARE CO LIMITED	THAILAND	$50.0K	1

Natco Pharma Limited supplies Imatinib to 17 buyers globally. The largest buyer is ATLANTA MEDICARE CO. LTD (THAILAND), followed by NATCO PHARMA (CANADA) INC (CANADA) and STADA ARZNEIMITTEL AG, (GERMANY). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Imatinib Formulations Does Natco Pharma Limited Export?

Product Description / Formulation	Value	Shipments
IMATINIB METHANE SULPHONATE INN(IMATINIB	$74.8K	2
IMATINIB TABLETS 400MG 30'S (3931X30'S PACK) (OTHER REF CI NO: 124025) (RODTEP ENTRY NO: 10112)	$68.2K	3
SANIS-IMATINIB 100MG TABLETS 30'S (APPEN	$55.4K	2
SANIS-IMATINIB 400MG TABLETS 30'S (OTHER	$50.0K	1
VEENAT 400MG TABLETS (IMATINIB 400MG) (	$50.0K	1
IMATINIB TABLETS 400MG 30 S (3862 PACK X	$50.0K	1
VEENAT/IMATINIB 100MG TABLETS 30'S (APPE	$50.0K	1
VEENAT/IMATINIB 100MG TABLETS 60'S (APPE	$50.0K	1
VEENAT/IMATINIB 100MG TABLETS 60'S (1542	$50.0K	1
VEENAT/IMATINIB 400MG TABLETS 30 S (3192X 30 S)(APPENDIX 4R RODTEP ENTRY NO:10112)(OTHER REF(S)CI NO:123125)	$50.0K	1

Natco Pharma Limited exports 29 distinct Imatinib formulations including tablets, capsules, syrups, and combination drugs. The top formulation is IMATINIB METHANE SULPHONATE INN(IMATINIB with 2 shipments worth $74.8K.

How Does Natco Pharma Limited Compare to Nearest Imatinib Exporters?

Exporters ranked immediately above and below #5 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
3	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$2.9M	72	7	$40.3K
4	JODAS EXPOIM PRIVATE LIMITED	$1.9M	38	3	$50.0K
5	NATCO PHARMA LIMITED ★	$1.3M	33	9	$39.7K
6	INTAS PHARMACEUTICALS LIMITED	$857.6K	19	6	$45.1K
7	ACCURE LABS PRIVATE LIMITED	$629.7K	20	2	$31.5K

Natco Pharma Limited ranks #5 among 224 Indian Imatinib exporters. Average shipment value of $39.7K compared to the market average of $82.5K. The closest competitors by value are SUN PHARMACEUTICAL INDUSTRIES LIMITED and JODAS EXPOIM PRIVATE LIMITED.

Which Indian Ports Ship Imatinib Exports?

Port	Shipments	% Share
SAHAR AIR	314	18.2%
SAHAR AIR CARGO ACC (INBOM4)	301	17.4%
DELHI AIR CARGO ACC (INDEL4)	235	13.6%
DELHI AIR	142	8.2%
Bombay Air	123	7.1%
HYDERABAD AIR	69	4.0%
HYDERABAD ACC (INHYD4)	61	3.5%
AHEMDABAD AIR	35	2.0%

Geopolitical & Trade Policy Impact on Natco Pharma Limited's Imatinib Exports

Natco's export operations are currently navigating a complex geopolitical landscape. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. These challenges are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and supply chain management. (pharmaceuticalcommerce.com)

In the United States, recent tariff implementations have introduced additional complexities for Indian pharmaceutical exporters. The U.S. administration's imposition of tariffs on imports from various countries, including India, has raised concerns about the competitiveness of Indian generics in the U.S. market. These tariffs could potentially erode profit margins and affect pricing strategies. (apnews.com)

Conversely, the European Union's stringent regulatory changes, such as the Falsified Medicines Directive, have heightened compliance requirements for exporters. While these regulations aim to ensure product authenticity and safety, they also necessitate significant investments in serialization and traceability systems. For companies like Natco, adhering to these standards is crucial for maintaining access to the lucrative EU market.

Natco Pharma Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing intensified scrutiny regarding quality and compliance. The U.S. Food and Drug Administration (FDA) has increased inspections of Indian manufacturing facilities, emphasizing adherence to Good Manufacturing Practices (GMP). Non-compliance can lead to warning letters, import alerts, or even bans, posing significant risks to exporters. (fact.net.in)

Natco's commitment to quality is evident in its proactive measures to meet international standards. The company's recent product approvals and successful market entries suggest a robust compliance framework. However, continuous vigilance and investment in quality systems are imperative to navigate the evolving regulatory landscape and to sustain export growth.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Imatinib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Natco Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 33 individual customs records matching Natco Pharma Limited exporting Imatinib, covering 29 formulations to 9 countries via 17 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 119+ countries, 456+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Imatinib

Imatinib

Natco Pharma Limited — Imatinib Exporter Profile

Natco Pharma Limited — Imatinib Export Profile: Buyers & Destinations

Where Does Natco Pharma Limited Export Imatinib?

Who Are the Top Buyers of Imatinib from Natco Pharma Limited?

What Is India's Total Imatinib Export Value and How Much Does Natco Pharma Limited Contribute?

What Is the Average Shipment Value for Natco Pharma Limited's Imatinib Exports?

How Does Natco Pharma Limited Compare to Other Indian Imatinib Exporters?

What Imatinib Formulations Does Natco Pharma Limited Export?

Regulatory Requirements: Exporting Imatinib to Key Markets

Germany — BfArM/EMA

Canada — HC

How Does Natco Pharma Limited Compare to Nearest Imatinib Exporters?

Which Indian Ports Ship Imatinib Exports?

What Other Advanced Oncology Products Does Natco Pharma Limited Export?

Imatinib — Export Intelligence Video

Geopolitical & Trade Policy Impact on Natco Pharma Limited's Imatinib Exports

Natco Pharma Limited — Regulatory Compliance & Quality Standards

About Natco Pharma Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Imatinib Export Data from Natco Pharma Limited

Imatinib Stats

Company Overview

Top Products by Natco Pharma Limited

Related Analysis

Need Detailed Export Data?

Data Source